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Introduction {#sec1}
============

Open chromatin is a global, constitutive feature of naive embryonic stem cells (ESCs), which are characterized by low levels of repressive histones and DNA methylation ([@bib7], [@bib14]). Diverse factors are required to maintain ESC chromatin in a decondensed state. They are important to stabilize pluripotency and to maintain the potential for self-renewal and differentiation. DPPA3 (also called PGC7 or Stella) is one of the factors known to modulate epigenetic processes in both embryonic and germ cell development ([@bib18]). It is a highly specific, maternal effect gene required for early embryonic cells and primordial germ cells (PGCs), and demarcates naive versus primed pluripotency ([@bib9], [@bib17]). Heterogeneous expression of DPPA3 was detected in ESC populations growing in Lif/serum as well as LIF/2i medium ([@bib9], [@bib23]). DPPA3 heterogeneity was concluded to result from a combination of low burst frequencies and large burst sizes ([@bib23]). DPPA3 is known to be involved in the maintenance of the low level of DNA methylation typical for early embryonic cells as well as ESCs ([@bib9]). At the same time, it protects imprinted loci against demethylation ([@bib15]). DPPA3 is required for the generation of fully reprogrammed pluripotent stem cells, in particular for the erasure of the epigenetic memory encoded in the DNA methylation pattern ([@bib27]).

Both ESCs and PGCs, the two cell types characterized by the expression of DPPA3, require the MAD2L2 protein for the proper establishment of their epigenetic status ([@bib19], [@bib20]). In the absence of Mad2L2 PGCs do not reprogram toward a more flexible chromatin configuration after their induction, and ESCs are not able to propagate their typical open chromatin, which is necessary for stable pluripotency.

MAD2L2 (also called REV7 or MAD2B) was originally identified by its function in DNA repair, playing an accessory role in translesion DNA repair and an inhibitory role in the resection of 5′ ends after DNA double-strand breaks and at unprotected telomeres ([@bib3], [@bib26]). As a downstream component of the DNA damage response pathway, MAD2L2 promotes non-homologous end joining versus homologous recombination. The role of MAD2L2 in DNA repair, ESC development, and PGC development is tightly connected to the epigenetic status of the respective cells. To investigate the relationship between MAD2L2 and the formation of open chromatin we compared wild-type and *Mad2l2*-deficient ESCs, employing super-resolution microscopy, transcriptome sequencing, methylome sequencing, and chromatin immunoprecipitation sequencing (ChIP-seq) analysis. We identified *Dppa3* as a downstream target of MAD2L2, and derived a model explaining the epigenetic effects of MAD2L2.

Results {#sec2}
=======

Heterogeneous Expression of MAD2L2 in ESCs {#sec2.1}
------------------------------------------

ESCs are known to express variable levels of specific RNAs and/or proteins, depending among other factors on growth conditions. This indicates a highly dynamic regulation of gene expression and reflects a metastable equilibrium between distinct cellular states. We characterized the MAD2L2 protein in wild-type ESCs and compared the dynamics with classical ESC markers. Individual cells of a colony expressed significantly different levels of MAD2L2 ([Figure 1](#fig1){ref-type="fig"}A and [Movie S1](#mmc2){ref-type="supplementary-material"}), either very high (4.8% out of 1,000 evaluated, cells from five different fields), high (72%), or low (23.2%), resembling the heterogeneity observed for DPPA3 expression ([Figure 3](#fig3){ref-type="fig"}A) ([@bib9]). In contrast, both MAD2L2-positive and -negative ESCs expressed Oct4 ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The differentiation of ESCs into epiblast-like cells (EpiLC) represents the transition from naive to primed pluripotency ([@bib10]). This was accompanied by a drastic downregulation of the MAD2L2 protein ([Figure S1](#mmc1){ref-type="supplementary-material"}B) and *Dppa3* mRNA ([Figure 3](#fig3){ref-type="fig"}C). Together, these observations suggest a dynamic fluctuation from a state of naive pluripotency demarcated by *Mad2l2* and *Dppa3* expression to a primed state with both markers off. EpiLCs can be further converted to unipotent PGC-like cells (PGCLCs), close in vitro equivalents of PGCs, on embryonic day 9 ([@bib10]). PGCLCs represent exactly the developmental stage at which a crucial function of MAD2L2 was previously demonstrated ([@bib19]). High expression levels of both MAD2L2 and DPPA3 are typical for germ cells including PGCLCs, and for naive ESCs ([Figures S2](#mmc1){ref-type="supplementary-material"}A and [3](#fig3){ref-type="fig"}C).

Association of MAD2L2 with Open Chromatin/Euchromatin {#sec2.2}
-----------------------------------------------------

In ESCs the MAD2L2 protein was associated with the chromatin fraction; however, it did not decorate condensed, mitotic chromosomes ([Figures 1](#fig1){ref-type="fig"}I and 1J). Super-resolution microscopy revealed that it was distributed in microfoci, not overlapping with the DNA-enriched heterochromatin near the nuclear lamina and around the nucleolus, as identified by H3K9me2 ([Figures 1](#fig1){ref-type="fig"}B and 1C) ([@bib25]). High levels of MAD2L2 protein were found in many ESCs of a colony in regions separate from transcriptionally inactive chromatin, as identified by H3K27me3 ([Figures 1](#fig1){ref-type="fig"}E and 1F). H3K27me3 accumulated in more central areas of ESC nuclei, compared with the peripheral localization of H3K9me2 ([Figures 1](#fig1){ref-type="fig"}C and 1E). ESC colonies always additionally contained cells with either predominantly MAD2L2 or predominantly H3K27me3, but not both, proteins ([Figures 1](#fig1){ref-type="fig"}D and 1F). More precisely, 70.6% of wild-type ESCs (out of 1,141 evaluated cells, from four fields) predominantly expressed MAD2L2 in the absence of H3K27me3, 23.6% had a non-overlapping expression of both MAD2L2 and H3K27me3, and 5.7% predominantly expressed H3K27me3 in the absence of MAD2L2. These numbers reflect the highly dynamic chromatin status in ESCs. Line scan histogram profiles through single nuclei demonstrated that MAD2L2 did not co-localize with compacted DNA and the heterochromatin markers H3K9me2, H3K27me3, and HP1α ([Figure S1](#mmc1){ref-type="supplementary-material"}C). In contrast to its exclusion from heterochromatin, MAD2L2 co-localized completely with the euchromatin identified by H3K4me3 and AcH4, which are the dominant histone modifications in ESCs growing in LIF/2i ([Figures 1](#fig1){ref-type="fig"}G and 1H).

Like ESCs, PGCLCs also express significant levels of MAD2L2 ([Figure S2](#mmc1){ref-type="supplementary-material"}A). To investigate whether MAD2L2 is instrumental for the balance between open and closed chromatin, we analyzed *Mad2l2*-deficient ESCs and PGCLCs. Mutant ESCs had an increased amount of heterochromatin, as indicated by the global levels of H3K9me2 and H3K27me3, and by a significantly increased number of cells with high levels of H3K9me2 and H3K27me3 ([Figure 1](#fig1){ref-type="fig"}K). The differentiation of ESCs via EpiLCs into PGCLCs was normally accompanied by the re-induction of the *Oct4*-GFP transgene and by a loss of the high levels of H3K9me2 typical for EpiLCs ([Figure S2](#mmc1){ref-type="supplementary-material"}B). However, *Mad2l2*-deficient PGCLCs maintained high levels of H3K9me2 and were not able to reprogram toward H3K27me3 ([Figure S2](#mmc1){ref-type="supplementary-material"}C). This resembled the initial induction of *Mad2l2-*deficient PGCs and their defective epigenetic reprogramming observed in vivo ([@bib19]). Taken together, we found a correlation between the presence of Mad2l2 and an open chromatin configuration, as is typical for naive pluripotency and germ cells after their epigenetic reprogramming. In the absence of *Mad2l2*, ESCs accumulated heterochromatin and lost their naive pluripotency. *Mad2l2*-deficient PGCLCs were locked in their stably repressed chromatin configuration.

Focus Formation in ESCs and Mitomycin-Treated MEFs {#sec2.3}
--------------------------------------------------

Not only MAD2L2, but also other DNA damage response factors accumulated in microfoci in the nuclei of ESCs, although there was no prior induction of DNA damage ([Figures 2](#fig2){ref-type="fig"}A--2C) ([@bib2], [@bib24]). Phosphorylation of histone H2AX and accumulation γH2AX foci around the sites of DNA breaks are usually an immediate-early response to DNA damage. In ESCs they were mainly localized, but not necessarily restricted, to areas of low DNA density ([Figure 2](#fig2){ref-type="fig"}A). Foci of the E3 ligase RNF168 and of the large adaptor protein 53BP1 were restricted to open chromatin, and their sizes were smaller, quite similar to the MAD2L2 microfoci ([Figures 2](#fig2){ref-type="fig"}B and 2C).

ESCs were co-cultured on feeder layers consisting of mitomycin-treated (i.e., DNA damaged) murine embryonic fibroblasts (mMEFs). This allowed a side-by-side comparison of foci formed in response to DNA damage with ESC foci ([Figures 2](#fig2){ref-type="fig"}D--2F). Mitomycin C-induced MAD2L2 foci varied widely in size (1--3.5 μm) in the intensity of staining for MAD2L2 and in numbers per nucleus, clearly due to the random nature of DNA damage induction. Focus sizes in ESCs were generally smaller (approximately 0.2--0.3 μm) and the numbers per cell were drastically higher, being homogeneously distributed throughout the open chromatin regions of ESC nuclei, separate from DAPI-stained, condensed heterochromatin ([Figures 2](#fig2){ref-type="fig"}D--2F). Thus, the parallel scanning of ESCs and mMEFs revealed an inverse relationship between the level of MAD2L2 and the presence of DAPI-stained heterochromatin. It also demonstrated the principal differences underlying focus formation in response to DNA damage and in ESCs.

Repression of the *Dppa3* Locus in the Absence of MAD2L2 {#sec2.4}
--------------------------------------------------------

We had previously compared the transcriptomes of *Mad2l2*-deficient and wild-type ESCs, and identified major transcriptional changes ([@bib19]). A re-evaluation of the transcriptome data (see [Experimental Procedures](#sec4){ref-type="sec"}) revealed that the fourth most significantly downregulated gene was *Dppa3* ([Figure 3](#fig3){ref-type="fig"}B). Downregulation of *Dppa3* in the absence of MAD2L2 was confirmed by RT-PCR for ESCs, EpiLCs, and PGCLCs ([Figure 3](#fig3){ref-type="fig"}C), and for ESCs also by immunofluorescence ([Figure 3](#fig3){ref-type="fig"}A). We used the BVSC cell line to visualize *Dppa3* expression by fluorescence of the DPPA3-eCFP fusion protein. DPPA3-positive and -negative ESCs were sorted based on expression of the ECFP reporter, and qPCR confirmed a positive correlation between *Dppa3* and *Mad2l2* levels. When sorted ESCs with a low level of DPPA3 were recultured in LIF/2i medium, 7% of the cells had upregulated the expression of *Dppa3*, suggesting that *Mad2l2* expression also could recover ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C).

ChIP-seq analysis of the *Dppa3* locus revealed that its transcriptional repression in *Mad2l2*-deficient ESCs was associated with the deposition of the repressive histone H3K9me2 in two positions upstream of the transcriptional start site ([Figure 3](#fig3){ref-type="fig"}D). The expression of *Dppa3* could be rescued by the introduction of a vector encoding a MAD2L2-GFP fusion protein into Mad2l2-deficient ESCs ([Figure 3](#fig3){ref-type="fig"}E). In this experiment the reactivation of the *Dppa3* gene occurred in the absence of DPPA3 protein. Thus, the initial effect of MAD2L2 was exerted independently of the epigenetic function(s) of DPPA3. Once derepressed, the *Dppa3* locus could be transcribed in ESCs, probably under control of the core pluripotency factor PRDM14, which was previously shown to be necessary for *Dppa3* expression in PGCLCs ([@bib13]). Remarkably, ESC colonies overexpressing GFP-MAD2L2 expressed DPPA3 as visualized by a *Dppa3-eCFP* transgene uniformly without an indication for heterogeneity ([Figure 3](#fig3){ref-type="fig"}F).

Global Increase of DNA Methylation, and Specific Demethylation of Imprinted Loci in *Mad2l2*-Deficient ESCs {#sec2.5}
-----------------------------------------------------------------------------------------------------------

We measured a significant increase of the global levels of 5-methylcytosine in *Mad2l2*-deficient ESCs compared with wild-type cells, although the high level found in EpiLCs was not reached ([Figure 4](#fig4){ref-type="fig"}A). Analysis of DNA methylation by methylated DNA immunoprecipitation sequencing (MeDIP-seq) confirmed the observed global difference, and allowed the display of DNA methylation at a single-nucleotide resolution ([Figure 4](#fig4){ref-type="fig"}B). These data revealed substantial, genome-wide perturbations of methylation patterns. For example, they demonstrated the presence of three methylation peaks instead of one around transcriptional start sites in mutant ESCs ([Figures 4](#fig4){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}). Noteworthy, however, is that the *Dppa3* gene and its upstream region remained largely unmethylated in both wild-type and mutant ESC. In early embryonic cells several genes maintain their methylation in a widely undermethylated epigenetic landscape, and consequently are transcriptionally repressed ([@bib8]). DPPA3 was previously shown to play a role in this imprinting of genes ([@bib4], [@bib11], [@bib15]). To study this process in *Mad2l2*-deficient, and consequently *Dppa3*-repressing, ESCs, we compared the RNA-seq datasets with the MeDIP-seq data. A total of 221 genes were methylated in wild-type ESCs but were unmethylated and transcriptionally upregulated in the *Mad2l2*-deficient ESCs ([Figure 4](#fig4){ref-type="fig"}D). Of these, the top five (*Peg3*, *Trp73*, *Ampd3*, *Mest*, and *Nnat*) were known imprinted genes (<http://www.geneimprint.com>). Taken together, the perturbation of DNA methylation in *Mad2l2*^−/−^ ESCs not only resulted in a general increase of methylation, but also affected imprinting through demethylation of specific loci. Although the *Mad2l2*-deficient ESCs were shown to be pluripotent and capable of contributing to chimeras ([@bib20]), they were not classified as naively pluripotent cells with regard to the increased level of DNA methylation.

Discussion {#sec3}
==========

The absence of MAD2L2 in mutant ESCs corresponds with the low MAD2L2 levels observed in somatic cells ([Figure 4](#fig4){ref-type="fig"}E). Cells with a low level of MAD2L2 have in common that the inhibitory binding of MAD2L2 to EHMT1 and EHMT2 is reduced ([@bib19]). Thus, histone H3 can be efficiently methylated on residue K9, and H3K9me2 can then form a docking place for further epigenetic regulators. DNA methyltransferase DNMT1 is recruited together with UHRF1 and EHMT2 at the replication fork, where it will also bind to proliferating cell nuclear antigen, and cooperatively to hemimethylated DNA ([@bib5], [@bib12], [@bib21]). Together, these and other interacting factors represent an assembly of both chromatin writers and readers, which maintain and establish a cell-specific chromatin configuration ([@bib12], [@bib22]). Collectively, the low levels of MAD2L2 and DPPA3 correspond to high levels of repressive histone modifications, substantial DNA methylation, and thus a closed chromatin configuration. In contrast, MAD2l2 levels are high in wild-type ESCs and PGCLCs, downstream of a cascade resembling the DNA damage response pathway ([Figures 1](#fig1){ref-type="fig"}A--1I and [S2](#mmc1){ref-type="supplementary-material"}A). In such cells MAD2L2 can directly bind to both EHMT1 and EHMT2, suppress EHMT2 expression, and thus inhibit histone H3K9 and DNA methylation ([@bib19]). By antagonizing the formation of H3K9me2, MAD2L2 will derepress the *Dppa3* gene. DPPA3 can then displace DNMT1 from UHRF1 at the replication fork, so that the growing strand cannot be methylated ([Figure 4](#fig4){ref-type="fig"}F; [@bib6]). In any case, the combined presence of MAD2L2 and DPPA3 in ESCs correlates with their generally low levels of both DNA and histone H3K9 methylation, i.e., a generally open chromatin configuration. In conclusion, the global promotion of open chromatin, and the inhibition of heterochromatin in ESCs and germ cells (PGCLCs and PGCs) depend critically on MAD2L2. The local opening of chromatin observed around DNA breaks may involve MAD2L2 and a similar mechanism ([@bib16]). It is conceivable that the major importance of MAD2L2 lies in its epigenetic functions, be it in a stem or germ cell context, or in response to DNA damage.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

*Mad2l2*-deficient ESCs carrying an *Oct4-GFP* allele ([@bib20]), and BVSC ESCs, with an insertion of the CFP reading frame into the *Dppa3* locus ([@bib17]) were cultured in LIF/2i medium ([@bib28]). For PGCLC formation, ESCs were first differentiated for 2 days into EpiLCs in the presence of activin and fibroblast growth factor, and subsequently for 6 days in PGCLC differentiation medium as described by [@bib10]. See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Flow Cytometry {#sec4.2}
--------------

Three independent biological replicates of 10,000 cells each were read by an Accuri C6 cytometer (BD Biosciences). See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Cell Fractionation {#sec4.3}
------------------

Three independent biological replicates were prepared from 10^8^ cells each, and were fractionated into cytoplasmic, nucleoplasmic, and chromatin fractions. See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

RT-PCR {#sec4.4}
------

At least three independent replicates, with two technical replicates each, were performed using the following primer pairs: Gapdh (5′-GTC GTG GAG TCT ACT GGT GTC-3′ and 5′-GAG CCC TTC CAC AAT GCC AAA-3′), Dppa3 (5′-CGT CCT ACA ACC AGA AAC AC-3′ and 5′-CTG CTC AAT CCG AAC AAG TC-3′), and Mad2l2 (5′-GTT GCC TTG AGT CCC TAC AG-3′ and 5′-TCC ACA TCG TTC TTC TCC AG-3′).

Immunocytochemistry {#sec4.5}
-------------------

Immunocytochemistry was performed as specified in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Sections were analyzed by confocal or stimulated emission depletion microscopy.

ChIP-Seq and MeDIP-Seq {#sec4.6}
----------------------

ChIP was performed for three independent replicates as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} ([@bib1]).

RNA-Seq {#sec4.7}
-------

Previously reported fastq files ([@bib20]) were re-evaluated as specified in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Dot Blot {#sec4.8}
--------

Dot-blot analysis was performed as described by [@bib10]. Three independent replicates of 50 ng DNA were applied to a membrane filter, and the methylation level was detected with an antibody against 5mC (Abcam).
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![MADL2 Localization in Relation to Open and Closed Chromatin of ESCs\
(A) Confocal microscopy of a colony with MAD2L2-positive and -negative ESCs.\
(B--F) STED microscopy of ESC sections (B, 50 nm; C--F, 80 nm) were analyzed by immunocytochemistry for (B) DNA, (C) H3K9me2, and (D--F) H3K27me3.\
(G) MAD2L2 expression in ESCs overlapped with euchromatin as identified by H3K4me2 (G) and AcH4 (H).\
(I) ESC with condensed chromosomes in the metaphase of the cell cycle. The cell was stained for DNA (DAPI, blue), and MAD2l2 (red), and analyzed by confocal microscopy.\
See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.\
(J) Fractionation of ESCs revealed that virtually the complete amount of MAD2L2 protein was in the chromatin fraction (Chr), and not in the cytoplasm (Cyto) or the nuclear fraction remaining after chromatin separation (Nuc).\
(K) The numbers of ESCs expressing high levels of H3K9me2 or H3K27me3 were significantly increased in the absence of MAD2L2.\
All observations in were confirmed with three experimental replicates. Scale bars represent 10 μm (A), 0.86 μm (B--F), 4 μm (G and H), and 10 μm (I).](gr1){#fig1}

![Microfoci of DNA Damage Response Factors in Wild-Type ESCs and Mitomycin-Treated MEFs\
(A--C) γH2AX, RNF168, and 53BP1 microfoci in ESCs.\
(D--F) Direct comparison of an ESC with a mMEF, which were scanned along the white line. The localization of proteins in comparison with DAPI was studied in at least 100 nuclei. (D) DAPI-intense DNA foci; the blue line compares average levels of DNA and numbers indicate condensed DNA foci. (E) MAD2L2 microfoci; the green line compares average levels of MAD2L2 protein, numbers indicate MAD2L2 foci, and white arrow points to the microfocus identified by an asterisk in the line scan histogram. (F) The merge of (D) and (E) compares directly DNA (DAPI) foci with the MAD2L2 foci. Black lines indicate the diameter of foci.\
Scale bars represent 10 μm (A--C) and 5 μm (F).](gr2){#fig2}

![*Dppa3* as a Target of MAD2L2\
(A) Levels of DPPA3 protein are heterogeneous in a colony of wild-type ESCs ([@bib9]), while no DPPA3 is detected in *Mad2l2*-deficient ESCs.\
(B) Comparison of transcriptomes from wild-type and *Mad2l2*-deficient ESCs. The volcano plot displays downregulated genes on the left and upregulated genes on the right. Black dots refer to insignificant changes, and red and green dots to statistically significant up- or downregulated genes, with a log~2~ fold-change cutoff. The arrow points to *Dppa3* as the fourth most strongly decreased gene.\
(C) *Dppa3* mRNA levels in ESCs, EpiLCs, and PGCLCs, in the presence (black) or absence (gray) of *Mad2l2*. SDs were calculated based on three experimental replicates.\
(D) Deposition of H3K9me2 is significantly increased in two specific positions upstream of the Dppa3 transcription start site (TSS) in Mad2l2-deficient ESCs. The TSS was taken from the Database of Transcriptional Start Sites (DBTSS, <http://dbtss.hgc.jp>). Three experimental replicates were performed.\
(E) RT-PCR analysis demonstrated the downregulation of Dppa3 expression in *Mad2l2*-deficient ESCs. Expression of *Dppa3* mRNA was efficiently rescued after transfection with an expression vector encoding a GFP-DPPA3 fusion protein. SDs were calculated based on three experimental replicates.\
(F) BVSC ESCs ([@bib17]) were transfected with *GFP-Mad2l2*, resulting in either completely GFP-positive or GFP-negative colonies. *Dppa3* expression was visualized by the blue fluorescence of ECFP protein originating from the transgene stably integrated in the endogenous *Dppa3* locus. Note the high, uniform expression of ECFP-DPPA3 in the Mad2l2-overexpressing colony, whereas the untransfected colony displayed normal heterogeneity. Three experimental replicates were performed.\
Scale bars represent 25 μm (A), 25 μm (E), and 50 μm (F). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![MAD2L2 Regulates DNA Methylation via DPPA3\
(A) The low level of 5mC detected by dot blots prepared from ESCs grown in LIF/2i conditions was significantly elevated in mutant ESCs, without, however, reaching the level detected in EpiLCs. This observation was confirmed with three experimental replicates.\
(B) 5mC-containing DNA fragments were immunoprecipitated and sequenced. This analysis revealed a global increase of DNA methylation in *Mad2l2*-deficient ESCs at single-base resolution. Three experimental replicates were performed.\
(C) The patterns of DNA methylation were significantly altered in the mutant ESCs. For instance, methylation around the transcription start site was distributed in a single peak in wild-type cells, whereas a three-peak pattern was observed in mutant ESCs. See also class III in [Figure S4](#mmc1){ref-type="supplementary-material"}. Red, green, and blue curves represent the values from three experimental replicates.\
(D) Direct comparison of RNA-seq data with the MeDIP data. The volcano plot compares expression of imprinted genes in *Mad2l2*-deficient ESCs with wild-type ESC; on the right are activated genes, on the left repressed genes. Black dots refer to insignificant changes, while red and green dots refer to significantly up- or downregulated genes with a log~2~ fold-change cutoff. Note that the top five genes (labeled with asterisks), which were both demethylated and transcriptionally activated in *Mad2l2*-deficient ESCs, are known imprinted genes.\
(E and F) Model for the binding of methyltransferases and interacting proteins near the replication fork. (E) The replication fork in the presence of low MAD2L2 levels as seen, for example, in somatic cells, *Mad2l2*^−/−^ ESCs, or *Mad2l2*^−/−^ PGCLCs. In the absence of MAD2L2 and DPPA3, H3K9me2 can contribute to the recruitment of DNMT1, UHRF1, EHMT1, and EHMT2. Consequently, the methylation of DNA and histones could proceed in coordinated fashion by the methyltransferases DNMT1 or EHMT1/2. (F) The replication fork in the presence of high MAD2L2 levels as seen, for example, in wild-type ESCs, PGCLCs, or *Mad2l2*-deficient ESCs transfected with a *Mad2l2-GFP* vector. MAD2L2 derepresses the *Dppa3* promoter by blocking EHMT1/2 and, thus, the formation of H3K9me2. The high level of DPPA3 displaces DNMT1 from UHRF1, and thus prevents methylation of the new DNA strand.](gr4){#fig4}
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